SCHEMBL8364865

SCHEMBL8364865

NC(=O)N1CCCCCCC1

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.55
F2 P00734 1/20 0.52
HPGD P15428 3/20 0.46
MMP1 P03956 1/20 0.46
MMP2 P08253 1/20 0.46
MMP3 P08254 1/20 0.46
MMP9 P14780 1/20 0.46
CA2 P00918 2/20 0.44
CHKA P35790 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.42
ATM Q13315 1/20 0.42
DPP7 Q9UHL4 1/20 0.41
POLB P06746 1/20 0.39
HTT P42858 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA9 Q16790 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14511334 1.00 ALDH1A1 (0.55) ALDH1A1F2HPGDMMP1MMP2
SCHEMBL2778162 1.00 ALDH1A1 (0.55) ALDH1A1F2HPGDMMP1MMP2
SCHEMBL1363949 1.00
SCHEMBL5457 1.00
SCHEMBL7749269 1.00 ALDH1A1 (0.55) ALDH1A1F2HPGDMMP1MMP2
SCHEMBL23963672 1.00 ALDH1A1 (0.55) ALDH1A1F2HPGDMMP1MMP2
SCHEMBL4129583 1.00 ALDH1A1 (0.55) ALDH1A1F2HPGDMMP1MMP2
Ammonia Solution, Strong SCHEMBL7413294 0.97 ALDH1A1 (0.52) ALDH1A1F2HPGDMMP1MMP2
Hydrochloric Acid SCHEMBL1649738 0.97 ALDH1A1 (0.52) ALDH1A1F2HPGDMMP1MMP2
SCHEMBL1086674 0.97 ALDH1A1 (0.52) ALDH1A1F2HPGDMMP1MMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5929067-A N-ACYLATING AMINE DERIVATIVE OF CAPROLACTAM COMPOUND WITH A CARBOXYLIC ACID OR DERIVATIVES TO FORM AMIDE DERIVATIVE OF CAPROLACTAM COMPOUND NOVARTIS AG (CH) 1999-07-27 US disclosed
EP-0810991-B1 1-ARYL-2-ACYLAMINO-ETHANE COMPOUNDS AND THEIR USE AS NEUROKININ ESPECIALLY NEUROKININ 1 ANTAGONISTS NOVARTIS AG (CH) 1999-04-14 EP disclosed
EP-0810991-A1 1-ARYL-2-ACYLAMINO-ETHANE COMPOUNDS AND THEIR USE AS NEUROKININ ESPECIALLY NEUROKININ 1 ANTAGONISTS Novartis AG (CH) 1997-12-10 EP disclosed
WO-1996026183-A1 1-ARYL-2-ACYLAMINO-ETHANE COMPOUNDS AND THEIR USE AS NEUROKININ ESPECIALLY NEUROKININ 1 ANTAGONISTS NOVARTIS AG (CH) 1996-08-29 WO disclosed